Publication:
Drugs in focus: Botulinum toxin in the therapy of gastrointestinal disorders in children

Simple item page
dc.contributor.authorTzivinikos, Christos
dc.date.accessioned2025-02-26T06:46:33Z
dc.date.available2025-02-26T06:46:33Z
dc.date.issued2024-12
dc.description.abstractWhat is Known: Botulinum toxin (BoNT) causes muscle relaxation by inhibiting acetylcholine release from presynaptic motor neurons at the neuromuscular junction. What is New: In children with achalasia, BoNT can be considered only in patients in whom rapid weight gain is important to improve surgical outcomes. BoNT has been suggested for treating cricopharyngeal achalasia and delayed gastric emptying. Anal achalasia and constipation after Hirschsprung disease corrective surgery are very promising indications for BoNT use. In selected children with resistant type of functional constipation and chronic anal fissure, BoNT is a viable option for treating.
dc.identifier.other39315663
dc.identifier.urihttps://repository.mbru.ac.ae/handle/1/1620
dc.language.isoen
dc.subjectconstipation
dc.subjectoesophagus
dc.subjectweight loss
dc.titleDrugs in focus: Botulinum toxin in the therapy of gastrointestinal disorders in children
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Drugs in focus Botulinum toxin in the therapy of gastrointestinal disorders in children.pdf
Size:
1.06 MB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Faculty Publications (CoM)